Adagene Inc. (ADAG) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$3.51
-1.40%
Mkt Cap $115.00M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 1, 2026 | $17.50M | $7.69M | -56.08% | -$0.28 | -$0.07 | +75.00% | — | — |
| Q1 2025 Mar 24, 2025 | — | $103.20K | — | -$0.33 | -$0.55 | -67.69% | — | — |
| Q3 2024 Jul 25, 2024 | — | — | — | -$0.41 | -$0.19 | +53.03% | — | — |
| Q1 2024 Mar 31, 2024 | — | — | — | — | -$0.19 | — | — | — |
| Q1 2024 Mar 29, 2024 | — | $407.87K | — | -$0.42 | -$0.17 | +59.76% | — | — |
| Q3 2023 Sep 30, 2023 | — | $407.87K | — | — | -$0.17 | — | — | — |
| Q3 2023 Aug 31, 2023 | — | $8.65M | — | -$0.38 | -$0.05 | +87.62% | — | — |
| Q1 2023 Mar 31, 2023 | — | $8.65M | — | — | -$0.05 | — | — | — |
| Q1 2023 Mar 28, 2023 | $9.94M | $2.68M | -72.99% | -$0.40 | -$1.55 | -287.50% | — | — |
| Q3 2022 Sep 30, 2022 | — | $2.68M | — | — | -$0.38 | — | — | — |
| Q3 2022 Aug 30, 2022 | $17.50M | $3.92M | -77.58% | -$0.65 | -$1.09 | -68.01% | — | — |
| Q3 2021 Sep 30, 2021 | — | $4.41M | — | — | -$0.41 | — | — | — |
| Q3 2021 Aug 26, 2021 | — | $1.36M | — | -$0.39 | -$1.02 | -161.89% | — | — |
| Q3 2020 Sep 30, 2020 | — | — | — | — | -$0.33 | — | — | — |
| Q2 2020 Jun 30, 2020 | — | $154.75K | — | — | -$0.72 | — | — | — |
| Q1 2020 Mar 31, 2020 | — | $154.75K | — | — | -$0.72 | — | — | — |
| Q4 2019 Dec 31, 2019 | — | $480.00K | — | — | -$0.15 | — | — | — |
| Q3 2019 Sep 30, 2019 | — | — | — | — | -$0.39 | — | — | — |
| Q2 2019 Jun 30, 2019 | — | — | — | — | -$0.30 | — | — | — |
| Q1 2019 Mar 31, 2019 | — | — | — | — | -$0.30 | — | — | — |